Anders Hamsten

87.8k total citations · 7 hit papers
382 papers, 30.0k citations indexed

About

Anders Hamsten is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Anders Hamsten has authored 382 papers receiving a total of 30.0k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Cardiology and Cardiovascular Medicine, 104 papers in Endocrinology, Diabetes and Metabolism and 89 papers in Surgery. Recurrent topics in Anders Hamsten's work include Diabetes, Cardiovascular Risks, and Lipoproteins (77 papers), Adipokines, Inflammation, and Metabolic Diseases (62 papers) and Lipoproteins and Cardiovascular Health (57 papers). Anders Hamsten is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (77 papers), Adipokines, Inflammation, and Metabolic Diseases (62 papers) and Lipoproteins and Cardiovascular Health (57 papers). Anders Hamsten collaborates with scholars based in Sweden, United Kingdom and United States. Anders Hamsten's co-authors include Per Eriksson, Ulf dé Fairé, Margareta Blombäck, Fredrik Karpe, Björn Wiman, Angela Silveira, Steve E. Humphries, Christian Landou, Per Tornvall and Jan Nilsson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Anders Hamsten

380 papers receiving 29.0k citations

Hit Papers

PLASMINOGEN ACTIVATOR INH... 1985 2026 1998 2012 1987 1985 2002 2005 1995 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
    1987 1.3k citations Anders Hamsten et al. profile →
  2. Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
    1985 1.1k citations Anders Hamsten, Ulf dé Fairé et al. profile →
  3. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study
    2002 796 citations Anders Hamsten et al. profile →
  4. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
    2005 728 citations Anders Hamsten et al. profile →
  5. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.
    1995 603 citations Per Eriksson, Anders Hamsten et al. profile →
  6. Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis
    1999 507 citations Per Eriksson, Anders Hamsten et al. Circulation profile →
  7. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man
    1992 502 citations Per Tornvall, Anders Hamsten et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anders Hamsten 8.2k 7.8k 6.4k 5.9k 5.7k 382 30.0k
Anne Tybjærg‐Hansen 9.3k 1.1× 7.4k 0.9× 11.0k 1.7× 4.6k 0.8× 5.1k 0.9× 345 28.3k
Lina Badimón 3.0k 0.4× 13.8k 1.8× 11.7k 1.8× 3.6k 0.6× 7.8k 1.4× 700 35.1k
Marie‐Christine Alessi 3.0k 0.4× 5.7k 0.7× 3.3k 0.5× 4.5k 0.8× 3.0k 0.5× 320 19.0k
Erik S.G. Stroes 6.8k 0.8× 8.2k 1.0× 13.9k 2.2× 3.2k 0.5× 5.1k 0.9× 496 29.5k
Jesús Egido 3.0k 0.4× 5.6k 0.7× 5.1k 0.8× 2.7k 0.5× 10.6k 1.9× 621 31.6k
François Cambien 7.0k 0.8× 10.0k 1.3× 3.2k 0.5× 2.1k 0.4× 3.9k 0.7× 229 20.8k
Arnold von Eckardstein 6.7k 0.8× 4.0k 0.5× 8.0k 1.3× 2.6k 0.4× 6.5k 1.1× 419 22.2k
Hermann Haller 3.5k 0.4× 4.8k 0.6× 4.1k 0.6× 2.0k 0.3× 7.0k 1.2× 454 23.0k
Subodh Verma 9.1k 1.1× 13.7k 1.8× 8.2k 1.3× 6.4k 1.1× 7.4k 1.3× 633 32.2k
Ton J. Rabelink 3.5k 0.4× 6.9k 0.9× 4.9k 0.8× 1.9k 0.3× 7.1k 1.2× 542 25.9k

Countries citing papers authored by Anders Hamsten

Since Specialization
Citations

This map shows the geographic impact of Anders Hamsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Hamsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Hamsten more than expected).

Fields of papers citing papers by Anders Hamsten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Hamsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Hamsten. The network helps show where Anders Hamsten may publish in the future.

Co-authorship network of co-authors of Anders Hamsten

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Hamsten. A scholar is included among the top collaborators of Anders Hamsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Hamsten. Anders Hamsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hoed, Marcel den, Rona J. Strawbridge, Peter Almgren, et al.. (2015). GWAS-identified loci for coronary heart disease are associated with intima-media thickness and plaque presence at the carotid artery bulb. Atherosclerosis. 239(2). 304–310. 28 indexed citations
3.
Bruzelius, Maria, Rona J. Strawbridge, David‐Alexandre Trégouët, et al.. (2014). Influence of coronary artery disease-associated genetic variants on risk of venous thromboembolism. Thrombosis Research. 134(2). 426–432. 15 indexed citations
4.
Song, Ci, Nancy L. Pedersen, Chandra A. Reynolds, et al.. (2013). Genetic Variants from Lipid-Related Pathways and Risk for Incident Myocardial Infarction. PLoS ONE. 8(3). e60454–e60454. 9 indexed citations
5.
Iglesias, María Jesús, Olof Emanuelsson, Bengt Sennblad, et al.. (2012). Correction: Combined Chromatin and Expression Analysis Reveals Specific Regulatory Mechanisms within Cytokine Genes in the Macrophage Early Immune Response. PLoS ONE. 7(4). 1 indexed citations
6.
Nyyssönen, K., Sudhir Kurl, Jouni Karppi, et al.. (2012). LDL oxidative modification and carotid atherosclerosis: Results of a multicenter study. Atherosclerosis. 225(1). 231–236. 10 indexed citations
7.
Folkersen, Lasse, Ferdinand van’t Hooft, Ekaterina Chernogubova, et al.. (2010). Association of Genetic Risk Variants With Expression of Proximal Genes Identifies Novel Susceptibility Genes for Cardiovascular Disease. Circulation Cardiovascular Genetics. 3(4). 365–373. 63 indexed citations
8.
Hopewell, Jemma C., Robert Clarke, Udo Seedorf, et al.. (2010). Abstract 17123: Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels. Circulation. 122. 1 indexed citations
9.
Bennermo, Marie, Margareta Nordin, Pia Lundman, et al.. (2010). Genetic and Environmental Influences on the Plasma Interleukin-6 Concentration in Patients with a Recent Myocardial Infarction: A Case–Control Study. Journal of Interferon & Cytokine Research. 31(2). 259–264. 34 indexed citations
10.
Hamsten, Anders, Angela Silveira, Susanna Boquist, et al.. (2005). The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men. Journal of the American College of Cardiology. 45(7). 1013–1017. 33 indexed citations
11.
Ehrenborg, Ewa, et al.. (2002). Common variants in genes encoding plasma lipid-transfer and lipolytic proteins are associated with increased LDL particle size. Circulation. 106. 169–169. 2 indexed citations
12.
Lundman, Pia, Maria J. Eriksson, Markus Stühlinger, et al.. (2001). Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. Journal of the American College of Cardiology. 38(1). 111–116. 197 indexed citations
13.
Ehrenborg, Ewa, et al.. (1999). Functional studies of a common promoter polymorphism in the microsomal triglyceride transfer protein gene (MTP). Circulation. 100. 197–197. 1 indexed citations
14.
Hamsten, Anders, et al.. (1998). Gene-gene interaction between apoB and apoE in determining plasma levels and heterogeneity of apoB-containing lipoproteins. Circulation. 98. 534–534. 2 indexed citations
15.
Karpe, Fredrik, Gene Bond, & Anders Hamsten. (1998). Remnant-like lipoproteins concentration in plasma is strongly associated with early signs of carotid atherosclerosis in healthy 50-year old men.. Circulation. 98. 451–451. 2 indexed citations
16.
Hamsten, Anders, et al.. (1998). Gene-gene interaction between apo E and apo B in determining plasma levels of apo B-containing lipoproteins. Atherosclerosis. 138. 1 indexed citations
17.
Eriksson, Per, et al.. (1996). A vldl response element in the promoter region of the human pai-1 gene implicated in the impaired fibrinolysis of hypertriglyceridaemia. Fibrinolysis & proteolysis. 10. 92. 2 indexed citations
18.
Karpe, Fredrik, George Steiner, Thomas Olivecrona, Lars A. Carlson, & Anders Hamsten. (1993). Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.. Journal of Clinical Investigation. 91(3). 748–758. 210 indexed citations
19.
Dawson, Sarah‐Jane, et al.. (1991). ALLELE SPECIFIC DIFFERENTIAL BINDING OF HEPG2 NUCLEAR EXTRACTS TO A COMMON POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) PROMOTER WHICH IS ASSOCIATED WITH ALTERED PLASMA PAI-1 LEVELS. UCL Discovery (University College London). 2 indexed citations
20.
Hamsten, Anders & Ulf dé Fairé. (1987). Risk factors for coronary artery disease in families of young men with myocardial infarction. The American Journal of Cardiology. 59(1). 14–19. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Tybjærg‐Hansen Breakdown of academic impact, for papers by Lina Badimón Breakdown of academic impact, for papers by Marie‐Christine Alessi Breakdown of academic impact, for papers by Erik S.G. Stroes Breakdown of academic impact, for papers by Jesús Egido Breakdown of academic impact, for papers by François Cambien Breakdown of academic impact, for papers by Arnold von Eckardstein Breakdown of academic impact, for papers by Hermann Haller Breakdown of academic impact, for papers by Subodh Verma Breakdown of academic impact, for papers by Ton J. Rabelink
Rankless by CCL
2026